Results 251 to 260 of about 938,469 (359)

Customer service in a channel of distribution : the case of the manufacturer - wholesaler - chain drug retailer channel in the prescription drug industry

, 1980
Frances Gaither Tucker
openalex   +1 more source

Versatile Cell Penetrating Peptide for Multimodal CRISPR Gene Editing in Primary Stem Cells

Advanced Functional Materials, EarlyView.
CRISPR machinery in diverse molecular formats (DNA, RNA, and ribonucleic protein) is complexed into nanoparticles with the cell‐friendly arginine‐alanine‐leucine‐alanine (RALA) cell‐penetrating peptide. Nanoparticles are delivered to primary mesenchymal stem cells ex vivo or locally in vivo to facilitate multimodal CRISPR gene editing. This RALA‐CRISPR
Joshua P. Graham, Jose Gabriel Castro, Lisette C. Werba, Joseph Amitrano, Luke Fardone, Kevin P. Francis, Anand Ramamurthi, Michael J. Layden, Helen O. McCarthy, Tomas Gonzalez‐Fernandez   +9 more
wiley   +1 more source

Technological and industrial trends in China's pharmaceutical sector. [PDF]

Front Pharmacol
Wang J, He M, Lu F, Chen Y, Wang H.
europepmc   +1 more source

Cu‐Based MOF/TiO2 Composite Nanomaterials for Photocatalytic Hydrogen Generation and the Role of Copper

Advanced Functional Materials, EarlyView.
HKUST‐1/TiO2 composite materials show a very high photocatalytic hydrogen evolution rate which increases as a function of the irradiation time until reaching a plateau and even surpasses the performance of the 1%Pt/TiO2 material after three photocatalytic cycles.
Alisha Khan, Marie Le Pivert, Alireza Ranjbari, Diana Dragoe, Daniel Bahena‐Uribe, Christophe Colbeau‐Justin, Christian Herrero, Dorota Rutkowska‐Zbik, Johnny Deschamps, Hynd Remita   +9 more
wiley   +1 more source

Analysis of Bacterial Coinfections in Patients with Mild, Moderate, and Severe COVID-19. [PDF]

Pol J Microbiol
Liu Q, Bei Gao J, Zheng Hu H, Zheng Jiao F, Gao X, Yan Wu B.   +5 more
europepmc   +1 more source

Innovation in the Pharmaceutical Industry: Evidence from Drug Introductions in the U.S.

, 2007
L.H. Pattikawa
openalex   +1 more source

A PROBLEMÁTICA DOS MONOPÓLIOS DAS INDÚSTRIAS DE MEDICAMENTOS E O DIREITO À SAÚDE: O CASO GLIVEC / THE PROBLEM OF MONOPOLY OF DRUG INDUSTRIES AND THE RIGHT TO HEALTH: THE GLIVEC CASE

, 2014
Natalia Brandini Zampieri
openalex   +2 more sources

Lipid Nanoparticles for the Delivery of CRISPR/Cas9 Machinery to Enable Site‐Specific Integration of CFTR and Mutation‐Agnostic Disease Rescue

Advanced Functional Materials, EarlyView.
Lipid nanoparticles (LNPs) are optimized to co‐deliver Cas9‐encoding messenger RNA (mRNA), a single guide RNA (sgRNA) targeting the endogenous cystic fibrosis transmembrane conductance regulator (CFTR) gene, and homologous linear double‐stranded donor DNA (ldsDNA) templates encoding CFTR.
Ruth A. Foley, Paul G. Ayoub, Vrishti Sinha, Colin Juett, Alicia Sanoyca, Emily C. Duggan, Lindsay E. Lathrop, Priyanka Bhatt, Kevin Coote, Beate Illek, Brigitte N. Gomperts, Donald B. Kohn, Steven J. Jonas   +12 more
wiley   +1 more source

Pharmaceutical governance system for costly drugs through human rights due diligence.

BMJ
Lemmens T, Ghimire KM, Perehudoff K, Kohler JC, Low E, Persaud N.   +5 more
europepmc   +1 more source

Dynamic clinical trial success rates for drugs in the 21st century. [PDF]

Nat Commun
Zhou Y, Zhang Y, Xu H, Chen Z, Huang S, Li Y, Fu J, Zhang H, Zhao D, Lian X, Zhou Y, Shen X, Liu K, Qiu Y, Wang Y, Xie W, Han L, Dai H, Zhu F.   +18 more
europepmc   +1 more source